DB:6LN

Stock Analysis Report

Health Insurance Innovations

Executive Summary

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States.

Snowflake

Fundamentals

High growth potential and slightly overvalued.

Share Price & News

How has Health Insurance Innovations's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.7%

6LN

2.6%

DE Insurance

1.7%

DE Market


1 Year Return

-41.1%

6LN

23.6%

DE Insurance

7.2%

DE Market

Return vs Industry: 6LN underperformed the German Insurance industry which returned 23.6% over the past year.

Return vs Market: 6LN underperformed the German Market which returned 7.2% over the past year.


Shareholder returns

6LNIndustryMarket
7 Day-1.7%2.6%1.7%
30 Day13.9%3.9%2.4%
90 Day25.7%3.9%2.3%
1 Year-41.1%-41.1%29.0%23.6%10.6%7.2%
3 Yearn/a69.7%49.2%18.4%8.1%
5 Yearn/a119.2%75.5%42.3%22.9%

Price Volatility Vs. Market

How volatile is Health Insurance Innovations's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Health Insurance Innovations undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 6LN (€23.8) is trading below our estimate of fair value (€60.26)

Significantly Below Fair Value: 6LN is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 6LN is poor value based on its PE Ratio (29.1x) compared to the Insurance industry average (13.4x).

PE vs Market: 6LN is poor value based on its PE Ratio (29.1x) compared to the German market (19x).


Price to Earnings Growth Ratio

PEG Ratio: 6LN is poor value based on its PEG Ratio (1.4x)


Price to Book Ratio

PB vs Industry: 6LN is overvalued based on its PB Ratio (4.6x) compared to the DE Insurance industry average (1.1x).


Next Steps

Future Growth

How is Health Insurance Innovations forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

21.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6LN's forecast earnings growth (21.2% per year) is above the savings rate (0.2%).

Earnings vs Market: 6LN's earnings (21.2% per year) are forecast to grow faster than the German market (12.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 6LN's revenue (11.4% per year) is forecast to grow faster than the German market (5% per year).

High Growth Revenue: 6LN's revenue (11.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6LN's Return on Equity is forecast to be very high in 3 years time (43.5%).


Next Steps

Past Performance

How has Health Insurance Innovations performed over the past 5 years?

50.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 6LN's earnings have grown significantly by 50.1% per year over the past 5 years.

Accelerating Growth: 6LN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6LN had negative earnings growth (-27.5%) over the past year, making it difficult to compare to the Insurance industry average (15.2%).


Return on Equity

High ROE: 6LN's Return on Equity (15.6%) is considered low.


Return on Assets

ROA vs Industry: 6LN has a higher Return on Assets than the Insurance industry average last year.


Return on Capital Employed

ROCE Improving: 6LN's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is Health Insurance Innovations's financial position? (This company is analysed differently as a bank or financial institution)


Financial Position Analysis


Debt to Equity History and Analysis


Balance Sheet

Inventory Level: 6LN has a low level of unsold assets or inventory.

Debt Coverage by Assets: 6LN's debt is covered by short term assets (assets are 1.524360x debt).


Financial Institutions Analysis

Asset Level: 6LN's level of assets compared to its equity is low.

Allowance for Bad Loans: Insufficient data to determine if 6LN has a sufficient allowance for bad loans.

Low Risk Liabilities: 6LN reports no customer deposits, loans are made up entirely of externally borrowed funds.

Loan Level: Insufficient data to determine if 6LN has an acceptable proportion of non-loan assets held.

Low Risk Deposits: 6LN has advanced significantly more loans than the customer deposits it holds.

Level of Bad Loans: Insufficient data to determine if 6LN has an appropriate level of bad loans.


Next Steps

Dividend

What is Health Insurance Innovations's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage3.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 6LN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 6LN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 6LN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 6LN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 6LN's dividend in 3 years as they are not forecast to pay a notable one for the German market.


Next Steps

Management

What is the CEO of Health Insurance Innovations's salary, the management and board of directors tenure and is there insider trading?

3.3yrs

Average management tenure


CEO

Gavin Southwell (41yo)

2.9yrs

Tenure

US$2,238,600

Compensation

Mr. Gavin Southwell has been Chief Executive Officer of Health Insurance Innovations, Inc. since November 15, 2016 and has been its President since July 2016. Mr. Southwell served as a Consultant of Healt ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether Gavin's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: Gavin's compensation has been consistent with company performance over the past year.


Management Age and Tenure

3.3yrs

Average Tenure

54yo

Average Age

Experienced Management: 6LN's management team is considered experienced (3.3 years average tenure).


Board Age and Tenure

2.9yrs

Average Tenure

57.5yo

Average Age

Experienced Board: 6LN's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellUS$13,83510 Jul 19
Michael Kosloske
EntityIndividual
Shares620
Max PriceUS$22.32
SellUS$1,170,70110 Jul 19
Michael Kosloske
EntityIndividual
Shares51,906
Max PriceUS$23.22
SellUS$1,802,99208 Jul 19
Michael Kosloske
EntityIndividual
Shares77,211
Max PriceUS$23.63
SellUS$1,189,99403 Jul 19
Michael Kosloske
EntityIndividual
Shares51,160
Max PriceUS$23.61
SellUS$930,90301 Jul 19
Michael Kosloske
EntityIndividual
Shares41,393
Max PriceUS$22.51
SellUS$2,414,74326 Jun 19
Michael Kosloske
EntityIndividual
Shares105,401
Max PriceUS$23.03
BuyUS$6,957,74117 Apr 19
Cannell Capital LLC
EntityCompany
Shares203,698
Max PriceUS$34.16
BuyUS$405,06610 Apr 19
Paul Gabos
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares15,000
Max PriceUS$27.00
BuyUS$78,43625 Mar 19
Paul Avery
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,000
Max PriceUS$26.15
BuyUS$2,338,84420 Mar 19
B. Riley Capital Management, LLC
EntityCompany
Shares90,742
Max PriceUS$25.77
BuyUS$78,83420 Mar 19
John Fichthorn
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares3,000
Max PriceUS$26.28
BuyUS$210,71120 Mar 19
Paul Gabos
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares8,000
Max PriceUS$26.34
BuyUS$15,554,55827 Dec 18
Cannell Capital LLC
EntityCompany
Shares386,197
Max PriceUS$40.28
SellUS$4,469,39027 Dec 18
Cannell Capital LLC
EntityCompany
Shares103,119
Max PriceUS$43.34
BuyUS$176,75018 Dec 18
Robert Murley
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares6,500
Max PriceUS$27.19

Ownership Breakdown


Management Team

  • Jeffrey Eisenberg (54yo)

    Consultant

    • Tenure: 5yrs
    • Compensation: US$10.00k
  • Gavin Southwell (41yo)

    President

    • Tenure: 2.9yrs
    • Compensation: US$2.24m
  • Mike Hershberger (56yo)

    CFO, Treasurer & Secretary

    • Tenure: 4.6yrs
    • Compensation: US$815.40k
  • Gerod Vernon

    Vice President of Sales

    • Tenure: 0yrs
  • Angela Bryant

    Senior VP & General Counsel

    • Tenure: 0yrs
  • Domenick DiCicco

    Chief Compliance Officer Counsel

    • Tenure: 0.3yrs
  • John Evans

    Investor Relations contact

    • Tenure: 3.8yrs
  • Mike DeVries

    Senior Vice President of Finance

    • Tenure: 0yrs
  • Jennifer Hammer

    Head of Strategic Initiatives Team

    • Tenure: 0.8yrs

Board Members

  • Paul Gabos (53yo)

    Non-Executive Chairman

    • Tenure: 2.9yrs
    • Compensation: US$191.50k
  • Paul Avery (59yo)

    Independent Director

    • Tenure: 6.7yrs
    • Compensation: US$137.50k
  • Bob Murley (69yo)

    Independent Director

    • Tenure: 5yrs
    • Compensation: US$137.50k
  • Peggy Scott (68yo)

    Independent Director

    • Tenure: 0.4yrs
  • John Fichthorn (46yo)

    Independent Director

    • Tenure: 1.8yrs
    • Compensation: US$130.00k
  • Gavin Southwell (41yo)

    President

    • Tenure: 2.9yrs
    • Compensation: US$2.24m
  • Anthony Barkett (72yo)

    Independent Director

    • Tenure: 6.6yrs
    • Compensation: US$151.50k
  • Ellen Duffield (56yo)

    Independent Director

    • Tenure: 0.4yrs

Company Information

Health Insurance Innovations, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Health Insurance Innovations, Inc.
  • Ticker: 6LN
  • Exchange: DB
  • Founded: 2008
  • Industry: Insurance Brokers
  • Sector: Insurance
  • Implied Market Cap: US$378.505m
  • Market Cap: US$293.829m
  • Listing Market Cap: US$339.747m
  • Shares outstanding: 14.18m
  • Website: https://www.hiiq.com

Number of Employees


Location

  • Health Insurance Innovations, Inc.
  • 15438 North Florida Avenue
  • Suite 201
  • Tampa
  • Florida
  • 33613
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HIIQNasdaqGM (Nasdaq Global Market)YesClass A Common StockUSUSDFeb 2013
6LNDB (Deutsche Boerse AG)YesClass A Common StockDEEURFeb 2013
0J3ULSE (London Stock Exchange)YesClass A Common StockGBUSDFeb 2013

Biography

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers s ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/22 21:49
End of Day Share Price2019/10/22 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.